NORFLOXACIN TABLET

Nchi: Kanada

Lugha: Kiingereza

Chanzo: Health Canada

Viambatanisho vya kazi:

NORFLOXACIN

Inapatikana kutoka:

AA PHARMA INC

ATC kanuni:

J01MA06

INN (Jina la Kimataifa):

NORFLOXACIN

Kipimo:

400MG

Dawa fomu:

TABLET

Tungo:

NORFLOXACIN 400MG

Njia ya uendeshaji:

ORAL

Vitengo katika mfuko:

100

Dawa ya aina:

Prescription

Eneo la matibabu:

QUINOLONES

Bidhaa muhtasari:

Active ingredient group (AIG) number: 0116961001; AHFS:

Idhini hali ya:

APPROVED

Idhini ya tarehe:

2018-02-08

Tabia za bidhaa

Page 1 of 42
PRODUCT MONOGRAPH
PR
NORFLOXACIN
Norfloxacin Tablets, USP
400mg
Antibacterial Agent
AA Pharma Inc.
DATE OF REVISION:
1165 Creditstone Road, Unit#1
June 25, 2019
Vaughan, Ontario
Canada L4K 4N7
Control # 226592
Page 2 of 42
PRODUCT MONOGRAPH
PR
NORFLOXACIN
Norfloxacin Tablets, USP
400 mg
THERAPEUTIC CLASSIFICATION
Antibacterial Agent
ACTIONS AND CLINICAL PHARMACOLOGY
Norfloxacin is a quinolone carboxylic acid antibacterial agent for
oral administration. Norfloxacin
inhibits bacterial deoxyribonucleic acid synthesis and is
bactericidal.
At the molecular level, three specific actions have been attributed to
norfloxacin in the inhibition of
E.coli cells:
1.
inhibition of the ATP-dependent DNA supercoiling reaction catalyzed by
DNA gyrase,
2.
inhibition of the relaxation of supercoiled DNA,
3.
promotion of double-stranded DNA breakage.
Comparative Bioavailability
A comparative bioavailability study was performed using healthy human
volunteers. The rate and
extent of absorption of norfloxacin following administration of a
single (one 400 mg tablet) dose of
Apo-Norflox and Noroxin were measured and compared. The results are
summarized as follows:
Summary Table of the Comparative Bioavailability Data
Norfloxacin (Dose: 400 mg) From Measured Data
Parameter
Geometric Mean
Arithmetic Mean (CV%)
Ratio of
Geometric
Means (%)**
Apo-Norflox
Noroxin
®
†
AUC
T
(ng•hr/ml)
7480
7870 (32)
7927
8247 (28)
94.3
AUC
I
(ng•hr/ml)
7895
8312 (33)
8367
8708
(28)
94.3
C
max
1501
1597
93.9
Page 3 of 42
Summary Table of the Comparative Bioavailability Data
Norfloxacin (Dose: 400 mg) From Measured Data
Parameter
Geometric Mean
Arithmetic Mean (CV%)
Ratio of
Geometric
Means (%)**
(ng/ml)
1562
(28)
1679
(31)
T
max
(hr)*
1.40
(51)
1.20
(30)
--
t
1/2
(hr)*
5.87
(15)
5.79
(14)
--
*Arithmetic means (CV%).
**Based on the least squares estimate.
†Noroxin
®
is manufactured by Merck, Sharp & Dohme, Div. of Merck Frosst Canada,
and was
purchased in Canada.
INDICATIONS AND CLINICAL USE
The treatment of upper and lower urinary tract i